Skip to content
★ Sign in to follow
DV

Daniel Vitt

Executive
Chief Executive Officer
Immunic, Inc.
Insider activity · 24 months2 buys0 salesCumulative net flow
Total declarations
8
Company
1
▲ Purchases (6 ops.)
€70k
▼ Sales (2 ops.)
€81k

Latest filing published 20 Jun 2025 for Immunic, INC., €10k.

Filing timeline

BuySale
Daniel Vitt

Insider track record

Disclosed buys
6
Disclosed sells
2
T+90 hit rate
25%
T+90 mean return
-8.0%

Across 4 buy signals with a settled T+90 return. Return basis: close on the day after publication.

Signal history

Daniel Vitt: trading record in brief

Daniel Vitt (chief executive) discloses dealings in Immunic, Inc. to SEC (Form 4). In total, 8 filings cover trades dated from 20 July 2020 to 4 June 2025.

Market trades split into 6 purchases (€70k) and 2 sales (€81k). Sales outweigh purchases by €10k. Unlike grants, an open-market purchase is paid for by the insider, at the market price. So far in 2025, the count stands at 2 purchases and no sales.

Half of the purchases are above €10k and half below. 4 out of 5 purchases came within 30 days of a purchase by at least one other insider of the same company. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time.

Most recently, on 20 June 2025, the filings show an open-market purchase worth €10k in Immunic, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.

Companies and markets linked to Daniel Vitt

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations6 total
  • ▲
    CEO and DirectorExecutivesImmunic, Inc.
    11,550 USD0SEC
    15,000 shares@ US$0.7714.4% of flowCommon StockSEC:0001193805-25-000923:0
    Canonical exit: 2 Sept 2025 (T+90)
  • ▲
    CEO and DirectorExecutivesImmunic, Inc.
    11,550 USD50SEC
    15,000 shares@ US$0.7716.8% of flowCommon StockSEC:0001193805-25-000821:0
    Canonical exit: 2 Sept 2025 (T+90)
  • ▲
    President and CEOExecutivesImmunic, Inc.
    18,333 USD36SEC
    14,000 shares@ US$1.309529.1% of flowCommon StockSEC:0001193805-24-000282:0
    Canonical exit: 26 May 2024 (T+90)
  • ▲
    President and CEOExecutivesImmunic, Inc.
    10,799 USD52SEC
    8,000 shares@ US$1.349918.1% of flowCommon StockSEC:0001193805-22-001602:0
    Canonical exit: 20 Feb 2023 (T+90)
  • ▲
    President and CEOExecutivesImmunic, Inc.
    15,500 USD48SEC
    5,000 shares@ US$3.099923.9% of flowCommon StockSEC:0001193805-22-000919:0
    Canonical exit: 1 Sept 2022 (T+90)
  • ▲
    President and CEOExecutivesImmunic, Inc.
    9,600 USD42SEC
    1,000 shares@ US$9.6013.6% of flowCommon StockSEC:0001193805-21-001161:0
    Canonical exit: 8 Nov 2021 (T+90)

6 of 6 declarations